News

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.…
Read More...

AstraZeneca and MSD’s selumetinib has been recommended for conditional marketing authorisation in the European Union (EU) for the treatment of symptomatic, inoperable plexiform…
Read More...

Pieris Pharmaceuticals, Inc. and Boston Pharmaceuticals announced that the companies have entered into an exclusive product license agreement to develop PRS-342, a 4-1BB/GPC3…
Read More...

CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced it has established a multi-year…
Read More...

Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20…
Read More...

Zenith Epigenetics Ltd. a clinical stage biotechnology company focused on the development of novel epigenetic combination therapies for the treatment of cancers, announces it has…
Read More...

Vertex Pharmaceuticals Incorporated and Obsidian Therapeutics announced that the two companies have entered into a strategic research collaboration and licensing agreement focused on…
Read More...

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on…
Read More...

Claritas Pharmaceuticals, Inc. announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CMAX”) to conduct a randomized, placebo-controlled, single-blind,…
Read More...

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring…
Read More...

A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate…
Read More...

ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium…
Read More...

PRA Health Sciences announced the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including…
Read More...

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, and OyaGen, Inc. (OyaGen), a pre-clinical biotechnology research company, announced an exclusive…
Read More...

Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in…
Read More...

Johnson & Johnson announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of the Company’s…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced a new supply agreement with Israel for 2022. Under the terms of this…
Read More...

Janux Therapeutics announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford…
Read More...

Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome. As Adare has committed to growing its Pharma Solutions and…
Read More...

Syneos Health the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform for patient-centered drug development, announced a strategic…
Read More...